Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »


  • MiReven
  • Ground Floor B Block
  • Sir Charles Gairdner Hospital, Hospital Avenue
  • Nedlands WA , 6009

MiReven was formed in 2010 through an investment from the Medical Research Commercialization Fund. The company is commercializing the pioneering work of Peter Leedman and Dr. Keith Giles at the Western Australian Institute for Medical Research (WAIMR) on the anti-cancer potential of miR-7. According to the company, miR-7 can knock-out an essential growth receptor for cancer, known as the epidermal growth factor receptor, as well as its associated signaling pathways that promote cancer development.

Related To This Company